Camphor toxicity: Difference between revisions
No edit summary |
Neil.m.young (talk | contribs) (Text replacement - "==Treatment==" to "==Management==") |
||
| Line 12: | Line 12: | ||
*Hepatitis and liver failure | *Hepatitis and liver failure | ||
== | ==Management== | ||
*Aggressive supportive care<ref>American Academy of Pediatrics Policy Statement. Camphor Revisited: Focus on Toxicity (RE9422). Pediatrics 1994;94:127-128</ref> | *Aggressive supportive care<ref>American Academy of Pediatrics Policy Statement. Camphor Revisited: Focus on Toxicity (RE9422). Pediatrics 1994;94:127-128</ref> | ||
*Benzodiazepines for seizure | *Benzodiazepines for seizure | ||
Revision as of 03:18, 8 July 2016
Background
- Common topical agent for pain relief, wart removal, osteoarthritis, cold sores
- FDA limits over the counter preparations to 11%[1]
- Highly lipophilic, widely and rapidly distributed, symptom onset 5-15 minutes
- CNS Stimulant when ingested
Clinical Features
- Nausea, vomiting, abdominal pain
- Oral burning, headache
- Vertigo, confusion, agitation
- Seizure, respiratory depression, coma
- Hepatitis and liver failure
Management
- Aggressive supportive care[2]
- Benzodiazepines for seizure
- Intubation and mechanical ventilation as needed
- Charcoal not likely effective